CLINICAL-PHARMACOLOGY OF HIGH-DOSE CISPLATIN

被引：70
|
作者：
CORDEN, BJ
FINE, RL
OZOLS, RF
COLLINS, JM
机构：
[1] NCI,DIV CANC TREATMENT,CLIN PHARMACOL BRANCH,BLDG 10,ROOM 6N119,BETHESDA,MD 20205
[2] NCI,DIV CANC TREATMENT,MED BRANCH,BETHESDA,MD 20205
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1985年 / 14卷 / 01期
关键词：
D O I：
10.1007/BF00552723
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：38 / 41
页数：4
相关论文
共 50 条
  • [21] CLINICAL-PHARMACOLOGY
    BRECKENRIDGE, A
    LANCET, 1984, 1 (8380): : 796 - 797
  • [22] CLINICAL-PHARMACOLOGY
    REIDENBERG, MM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (21): : 1664 - 1665
  • [23] CLINICAL-PHARMACOLOGY
    REIDENBERG, MM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (23): : 3107 - 3109
  • [24] CLINICAL-PHARMACOLOGY
    REIDENBERG, MM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (19): : 2831 - 2832
  • [25] CLINICAL-PHARMACOLOGY BENZODIAZEPINES - DOSE AND PHARMACOKINETICS ARE THE MAJOR DIFFERENCES
    BOURIN, M
    GAZETTE MEDICALE DE FRANCE, 1982, 89 (36): : 4407 - 4408
  • [26] CLINICAL-PHARMACOLOGY OF INTERMEDIATE-DOSE ORAL METHOTREXATE
    SMITH, DK
    OMURA, GA
    OSTROY, F
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1980, 4 (02) : 117 - 120
  • [27] EVOLUTION OF HIGH-DOSE CISPLATIN
    HOLLERAN, WM
    DEGREGORIO, MW
    INVESTIGATIONAL NEW DRUGS, 1988, 6 (02) : 135 - 142
  • [28] CLINICAL-PHARMACOLOGY - MEDICINE OR PHARMACOLOGY
    SOMBERG, JC
    JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 32 (09): : 773 - 773
  • [29] CLINICAL-PHARMACOLOGY OF WEEKLY LOW-DOSE EPIRUBICIN
    SCHEULEN, ME
    MILLER, AA
    NIEDERLE, N
    SCHMIDT, CG
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 153 - 153
  • [30] CLINICAL PHARMACOLOGY OF HIGH-DOSE METHOTREXATE (NSC-740)
    TATTERSALL, MHN
    PARKER, LM
    PITMAN, SW
    FREI, E
    CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (01): : 25 - 29
12345